Journal
JOURNAL OF CLINICAL MICROBIOLOGY
Volume 48, Issue 11, Pages 4248-4250Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.00896-10
Keywords
-
Categories
Funding
- Research Foundation Flanders (FWO) [G.0466.10N]
- Boehringer Ingelheim
Ask authors/readers for more resources
The ability of Staphylococcus aureus to clot plasma through conformational activation of prothrombin by staphylocoagulase is used to distinguish S. aureus from coagulase-negative staphylococci. We show that while the direct thrombin inhibitor dabigatran inhibits staphylocoagulase activity, the clinical use of dabigatran etexilate is not expected to interfere with direct tube coagulase testing.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available